General Range
FORLIC DS 457
Price on request/100 · MOQ 100 boxes
FORLIC DS 457 Dry Syrup by Fortune Labs contains Amoxicillin 400 mg and Potassium Clavulanate 57 mg per 5 ml, a combination antibiotic used to treat susceptible bacterial infections in children. Amoxicillin inhibits bacterial cell wall synthesis, while Potassium Clavulanate protects it against certain bacterial resistance enzymes. FORLIC DS 457 may be prescribed for ear infections, sinusitis, respiratory tract infections, urinary tract infections, and skin infections when clinically appropriate. Available in convenient 30 ml pediatric dry syrup packaging with water for reconstitution, this product is part of Fortune Labs' pharmaceutical range. Fortune Labs offers Pediatric PCD Pharma Franchise and distribution opportunities across India. Contact the company for wholesale pricing, product availability, and franchise enquiries. Use only as prescribed.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Amoxicillin 400 mg + Potassium Clavulanate 57 mg per 5 ml
- Packaging Type
- Dry Syrup Bottle with Outer Carton and Water for Reconstitution
- Packaging Size
- 30 ml
- Dosage Form
- Oral Suspension
- Treatment
- Bacterial respiratory tract infections, throat infections, ear infections, sinusitis, urinary tract infections, and certain skin and soft tissue infec
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
